Gene therapy for rheumatoid arthritis. Theoretical considerations
Current understanding of the pathogenesis of rheumatoid arthritis has provided evidence that therapeutic benefit can be achieved by using antagonists targeted to the inflammatory cytokines involved, mainly tumour necrosis factor-α and interleukin-1. Gene delivery of antagonists, which can inhibit th...
Guardado en:
| Autor principal: | |
|---|---|
| Publicado: |
1998
|
| Materias: | |
| Acceso en línea: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_1170229X_v12_n1_p29_Chernajovsky http://hdl.handle.net/20.500.12110/paper_1170229X_v12_n1_p29_Chernajovsky |
| Aporte de: |